The COVID-19 vaccines developed for the 2024-2025 respiratory disease season were around 75% effective at preventing ...

In a recent article published in Nature Communications, researchers investigated whether messenger ribonucleic acid (mRNA) technology-based coronavirus disease 2019 (COVID-19) vaccines promote the ...

Harnessing the power of a single dose, this innovative vaccine offers a potent defense against both current and future COVID-19 threats. Study: A single-dose intranasal live-attenuated codon ...

Future Virology. 2013;8(1):1-2. During the global 2002/2003 SARS pandemic, many foundations, pharmaceutical companies and governments provided abundant funds to support the development of anti-SARS ...

Canadian researchers say they have developed two potential vaccines against SARS that they will begin testing on animals next week. Human tests could begin within a year. It is still not clear if it ...

Higher immune responses were elicited by mRNA-1083 than high-dose quadrivalent inactivated influenza vaccine for all 4 influenza strains and high-dose quadrivalent inactivated influenza vaccine for 3 ...

GALVESTON - A chance discovery by researchers here may have opened the door wider to creation of a vaccine against SARS, the virus that swept out of southern China in 2003 and killed one of every 10 ...

Expert Rev Vaccines. 2009;8(7):887-898. Severe acute respiratory syndrome (SARS) caused thousands of human infections worldwide and hundreds of deaths in just a few months, and severely impacted the ...

Instead of dealing with big technical issues in the usual one-by-one order, scientists will jump into all of them at once. For instance, they are gearing up production of newly minted vaccines at the ...

When SARS struck more than 8,000 people and killed nearly 800 in the spring of 2003, the world clamored to know when a vaccine against the deadly virus would come to the rescue. Vaccine manufacturers ...